Rallybio
Rallybio is a clinical-stage biotechnology company built around a team of seasoned industry leaders.
2
Funding Rounds
$118.0m
Money raised
Overview
Rallybio is a clinical-stage biotechnology company built around a team of seasoned industry leaders.
- Website:
- Headquarters: New Haven, Connecticut
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Ma**** | - | - | - |
| Je***** Fr*** | - | - | - |
| St*** Ud** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Ma**** | - | - | - |
| We*** Ch*** | - | - | |
| Lu**** Ia******* | - | - | - |
| Ku** Pa**** | - | - | - |
| Ro* Ho***** | - | - | - |
| Ch******* A. Na** | - | - | - |
| Pa*** So********** | - | - | |
| He*** M. Bo****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Rallybio has raised a total of $118m in funding over 2 rounds.
Key Insights:
- Rallybio Initial public offering (IPO): $81m
- Rallybio Series A round, April 2018: $37m
Rallybio Initial public offering (IPO)
$81m
Rallybio Series A round, April 2018
$37m
Industries
Rallybio is active in the following industries:
- Rare disease
- Biomedical engineering
- Engineering
- Technology
- Biology
- Biotechnology